Kelley, Robin Kate ;
Ueno, Makoto ;
Yoo, Changhoon...
The KEYNOTE-966 Investigators , Kelley , R K , Ueno , M , Yoo , C , Finn , R S , Furuse , J , Ren , Z , Yau , T , Klümpen , H-J , Chan , S L , Ozaka , M , Verslype , C , Bouattour , M , Park , J O , Barajas , O , Pelzer , U , Valle , J W , Yu , L , Malhotra , U , Siegel , A B , Edeline , J & Vogel , A 2023 , ' Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial ' , The Lancet . https://doi.org/10.1016/S0140-6736(23)00727-4.
,
2023
